| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Metabolic Diseases, and
Department of Clinical Bioinformatics, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan
Abstract
Obesity and insulin resistance have been recognized as leading causes of major health issues. We have endeavored to depict the molecular mechanism of insulin resistance, focusing on the function of adipocyte.
We have investigated a role of PPAR
on the pathogenesis of Type II diabetes. Heterozygous PPAR-deficient mice were protected from the development of insulin resistance due to adipocyte hypertrophy under a high-fat diet. Moreover, a Pro12Ala polymorphism in the human PPAR2 gene was associated with decreased risk of Type II diabetes in Japanese. Taken together with these results, PPAR is proved to be a thrifty gene mediating Type II diabetes. Pharmacological inhibitors of PPAR/RXR ameliorate high-fat diet-induced insulin resistance in animal models of Type II diabetes.
We have performed a genome-wide scan of Japanese Type 2 diabetic families using affected sib pair analysis. Our genome scan reveals at least 9 chromosomal regions potentially harbor susceptibility genes of Type II diabetes in Japanese. Among these regions, 3q26-q28 appeared to be very attractive one, because of the gene encoding adiponectin, the expression of which we had found enhanced in insulin-sensitive PPAR-deficient mice. Indeed, the subjects with the G/G genotype of SNP276 in the adiponectin gene were at increased risk for Type II diabetes compared with those having the T/T genotype. The plasma adiponectin levels were lower in the subjects with the G allele, suggesting that genetically inherited decrease in adiponectin levels predispose subjects to insulin resistance and Type II diabetes. Our work also confirmed that replenishment of adiponectin represents a novel treatment strategy for insulin resistance and Type II diabetes using animal models. Further investigation will be needed to clarify how adiponectin exerts its effect and to discover the molecular target of therapies.
Key Words: adiponectin • PPAR • insulin resistance • obesity • adipocyte
This article has been cited by other articles:
|
|
 |
|
  M. Kondo, H. Maegawa, T. Obata, S. Ugi, K. Ikeda, K. Morino, Y. Nakai, Y. Nishio, S. Maeda, and A. Kashiwagi Transcription Factor Activating Protein-2{beta}: A Positive Regulator of Monocyte Chemoattractant Protein-1 Gene Expression Endocrinology, April 1, 2009; 150(4): 1654 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Caricilli, P. H Nascimento, J. R Pauli, D. M L Tsukumo, L. A Velloso, J. B Carvalheira, and M. J A Saad Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet J. Endocrinol., December 1, 2008; 199(3): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ikeda, S. Sakaue, M. Kamigaki, H. Ohira, N. Itoh, Y. Ohtsuka, I. Tsujino, and M. Nishimura Knockdown of Macrophage Migration Inhibitory Factor Disrupts Adipogenesis in 3T3-L1 Cells Endocrinology, December 1, 2008; 149(12): 6037 - 6042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shimada, N. Hiramatsu, A. Kasai, M. Mukai, M. Okamura, J. Yao, T. Huang, M. Tamai, S. Takahashi, T. Nakamura, et al. Suppression of adipocyte differentiation by Cordyceps militaris through activation of the aryl hydrocarbon receptor Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E859 - E867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nishigaki, K. Kobayashi, T. Hitomi, T. Yokomura, M. Yokoyama, N. Seki, and K. Kazuma Perception of Offspring Risk for Type 2 Diabetes Among Patients With Type 2 Diabetes and Their Adult Offspring Diabetes Care, December 1, 2007; 30(12): 3033 - 3034. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Varady, D. J. Roohk, Y. C. Loe, B. K. McEvoy-Hein, and M. K. Hellerstein Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice J. Lipid Res., October 1, 2007; 48(10): 2212 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, M. M. Masternak, K. A. Al-Regaiey, and A. Bartke Adipocytokines and the Regulation of Lipid Metabolism in Growth Hormone Transgenic and Calorie-Restricted Mice Endocrinology, June 1, 2007; 148(6): 2845 - 2853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Han, M. J. Quon, J.-a Kim, and K. K. Koh Adiponectin and Cardiovascular Disease: Response to Therapeutic Interventions J. Am. Coll. Cardiol., February 6, 2007; 49(5): 531 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Asato, K. Katsuren, T. Ohshiro, K. Kikawa, T. Shimabukuro, and T. Ohta Relationship Between Lipid Abnormalities and Insulin Resistance in Japanese School Children Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2781 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ikeda, H. Maegawa, S. Ugi, Y. Tao, Y. Nishio, S. Tsukada, S. Maeda, and A. Kashiwagi Transcription Factor Activating Enhancer-binding Protein-2beta: A NEGATIVE REGULATOR OF ADIPONECTIN GENE EXPRESSION J. Biol. Chem., October 20, 2006; 281(42): 31245 - 31253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ota, K. Ito, T. Suzuki, S. Saito, M. Tamura, S.-i. Hayashi, K. Okamura, H. Sasano, and N. Yaegashi Peroxisome Proliferator-Activated Receptor {gamma} and Growth Inhibition by Its Ligands in Uterine Endometrial Carcinoma. Clin. Cancer Res., July 15, 2006; 12(14): 4200 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, K. A. Al-Regaiey, M. M. Masternak, and A. Bartke Adipocytokines and lipid levels in ames dwarf and calorie-restricted mice. J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 323 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tao, H. Maegawa, S. Ugi, K. Ikeda, Y. Nagai, K. Egawa, T. Nakamura, S. Tsukada, Y. Nishio, S. Maeda, et al. The Transcription Factor AP-2{beta} Causes Cell Enlargement and Insulin Resistance in 3T3-L1 Adipocytes Endocrinology, April 1, 2006; 147(4): 1685 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Quyyumi Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S66 - S71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Higami, J. L. Barger, G. P. Page, D. B. Allison, S. R. Smith, T. A. Prolla, and R. Weindruch Energy Restriction Lowers the Expression of Genes Linked to Inflammation, the Cytoskeleton, the Extracellular Matrix, and Angiogenesis in Mouse Adipose Tissue J. Nutr., February 1, 2006; 136(2): 343 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Mitchell, D T Armstrong, R L Robker, and R J Norman Adipokines: implications for female fertility and obesity Reproduction, November 1, 2005; 130(5): 583 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Salmenniemi, J. Zacharova, E. Ruotsalainen, I. Vauhkonen, J. Pihlajamaki, S. Kainulainen, K. Punnonen, and M. Laakso Association of Adiponectin Level and Variants in the Adiponectin Gene with Glucose Metabolism, Energy Expenditure, and Cytokines in Offspring of Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4216 - 4223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Meier and A. M. Gressner Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin Clin. Chem., September 1, 2004; 50(9): 1511 - 1525. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
